{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T12:35:59Z","timestamp":1753878959648,"version":"3.41.2"},"reference-count":23,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2024,10,13]],"date-time":"2024-10-13T00:00:00Z","timestamp":1728777600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Transplant Infectious Dis"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Cytomegalovirus (CMV) is a significant cause of morbidity and mortality in solid organ transplant recipients (SOTRs). Secondary prophylaxis (SP) is not routinely recommended by guidelines on the management of CMV in SOTR but may be considered in certain higher\u2010risk situations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A comprehensive search of English language publications up to September 2023 was performed. The primary outcome was CMV relapse, defined as the recurrence of DNAemia or disease. Secondary outcomes included graft loss, mortality, and hematological toxicity. Meta\u2010analysis used the random\u2010effects model. The study protocol is registered in PROSPERO (no. CRD42022357028).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Six retrospective comparative studies were included. A total of 520\/727 (72%) of SOTR received SP with valganciclovir. The meta\u2010analysis did not demonstrate a significant difference in CMV relapse (odds ratio [OR] 1.15, 95% confidence interval [CI] 0.79\u20132.63). Heterogeneity between the studies was low (<jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup> = 0%, <jats:italic>p<\/jats:italic> = 0.57). SP was significantly associated with a reduction in mortality (OR 0.2, 95% CI 0.07\u20130.54) but not graft loss (OR 0.67, 0.17\u20132.63). There was no significant difference in CMV relapse among kidney\u2010specific SOTR (OR 1.38, 95% CI 0.65\u20132.96).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Evidence from six nonrandomized studies is limited and cannot support a recommendation for or against routine SP in SOTR treated for CMV infection. Awaiting prospective\u2010controlled trials, the decision about SP should depend on individualized risk\u2010profile assessments by experienced clinicians.\n<jats:boxed-text content-type=\"graphic\" position=\"anchor\"><jats:graphic xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" mimetype=\"image\/png\" position=\"anchor\" specific-use=\"enlarged-web-image\" xlink:href=\"graphic\/tid14393-gra-0001-m.png\"><jats:alt-text>image<\/jats:alt-text><\/jats:graphic><\/jats:boxed-text><\/jats:p><\/jats:sec>","DOI":"10.1111\/tid.14393","type":"journal-article","created":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T06:13:53Z","timestamp":1728886433000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Secondary anti\u2010viral prophylaxis in solid organ transplant recipients for the prevention of cytomegalovirus relapse: A systematic review and meta\u2010analysis"],"prefix":"10.1111","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0631-0873","authenticated-orcid":false,"given":"David","family":"Moynan","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases Mater Misericordiae University Hospital  Dublin Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eibhlin","family":"Higgins","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases University Hospital Galway  Galway Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Passerini","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology and Transplantation University of Milano  Milan Italy"},{"name":"Department of Infectious Diseases ASST FBF SACCO Fatebenefratelli  Milan Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larry J.","family":"Prokop","sequence":"additional","affiliation":[{"name":"Mayo Clinic Libraries Mayo Clinic  Rochester Minnesota USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Hassan","family":"Murad","sequence":"additional","affiliation":[{"name":"Evidence\u2010Based Practice Center Mayo Clinic  Rochester Minnesota USA"},{"name":"Department of Medicine Division of Public Health Infectious Diseases and Occupational Medicine and the William J. von Liebig Center for Transplantation and Clinical Regeneration Mayo Clinic  Rochester Minnesota USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5248-0227","authenticated-orcid":false,"given":"Raymund R.","family":"Razonable","sequence":"additional","affiliation":[{"name":"Department of Medicine Division of Public Health Infectious Diseases and Occupational Medicine and the William J. von Liebig Center for Transplantation and Clinical Regeneration Mayo Clinic  Rochester Minnesota USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2024,10,13]]},"reference":[{"key":"e_1_2_10_2_1","first-page":"373","volume-title":"Clinical Virology Manual","author":"Pancholi P","year":"2023"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/CID\/CIX696"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.6061\/CLINICS\/2015(07)09"},{"volume-title":"UK Guideline on Prevention and Management of Cytomegalovirus (CMV) Infection and Disease Following Solid Organ Transplantation","year":"2021","author":"British Transplant Society","key":"e_1_2_10_5_1"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/CTR.13512"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/TID.12873"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0B013E3181FF1493"},{"volume-title":"Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV","year":"2024","author":"Panel on Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV","key":"e_1_2_10_9_1"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/OFID\/OFAA439.1265"},{"volume-title":"Covidence Systematic Review Software","year":"2024","author":"Veritas Health Innovation","key":"e_1_2_10_11_1"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/S10654\u2010010\u20109491\u2010Z"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.18637\/JSS.V049.I05"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00120\u2010021\u201001471\u20102"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000000386"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/TRI.12378"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000001338"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/J.1432\u20102277.2011.01321.X"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/TID.13189"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/CID\/CIW084"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088\u2010199937020\u201000005"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.3947\/IC.2013.45.3.260"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000002396"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/CTR.15143"}],"container-title":["Transplant Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/tid.14393","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T04:52:55Z","timestamp":1735015975000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/tid.14393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,13]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["10.1111\/tid.14393"],"URL":"https:\/\/doi.org\/10.1111\/tid.14393","archive":["Portico"],"relation":{},"ISSN":["1398-2273","1399-3062"],"issn-type":[{"type":"print","value":"1398-2273"},{"type":"electronic","value":"1399-3062"}],"subject":[],"published":{"date-parts":[[2024,10,13]]},"assertion":[{"value":"2024-09-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e14393"}}